Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Evolving etiologies of liver transplantation: a trend analysis from 2020 to 2024 at the main center of Iran
Gastroenterology and Hepatology from Bed to Bench
2025
Jamalinia M.
New insights into potential biomarkers and their roles in biological processes associated with hepatitis C-related liver cirrhosis by hepatic RNA-seq-based transcriptome profiling
Virus Research
November 2024
Nasr Azadani H.
Open Access
Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies
Journal of Viral Hepatitis
September 2024
Mousavi S.F.
Review of Hepatocellular Carcinoma and Liver Disease Prevalence
New Emirates Medical Journal
2024
Tolou-Ghamari Z.
Open Access
Predictors for Liver Cirrhosis in Patients with Hepatitis C Virus: A Cross-Sectional Study
Hepatitis Monthly
Dec 2023
Namazi A.
Open Access
Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study
International Journal of Prisoner Health
28 November 2023
SeyedAlinaghi S.A.
Knowledge and awareness of chronic hepatitis C and liver fibrosis among health care personnel and other domains in Iraq
Bionatura
2023
Mohsen S.M.
Open Access
Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Infections Among People with Severe Mental Illness in Tehran, Iran
Hepatitis Monthly
Dec 2022
Imani M.
Open Access
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
BMJ Open
8 June 2022
Tasavon Gholamhoseini M.
Open Access
Effect of Atorvastatin on Single Oral Pharmacokinetics and Safety of Daclatasvir in Rats: Emphasis on P-glycoprotein and Cytochrome P450
Current Drug Metabolism
May 2022
Elbadawy H.A.
MicroRNA let-7b inhibits hepatitis C virus and induces apoptosis in human hepatoma cells
Molecular Biology Reports
February 2022
Jamalidoust M.
An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran
International Journal of Drug Policy
September 2021
Hariri S.
Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases
Gastroenterology and Hepatology from Bed to Bench
September 2021
Mokhtari F.
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus
International Journal of Clinical Practice
August 2021
Dehghan Manshadi S.A.
Changes in liver fibrosis in patients with chronic hepatitis C after successful direct-acting antiviral therapy
International Journal of Clinical Practice
June 2021
Sadeghi A.
Hepatitis C rapid point-of-care testing and laboratory-based non-invasive assessment of liver fibrosis among drug abusers: An experience from Iran
Archives of Iranian Medicine
February 2021
Hedayati-Moghaddam M.R.
Open Access
Seroprevalence and associated factors of hepatitis B and C virus among pulmonary tuberculosis patients attending health facilities in Gondar Town, Northwest Ethiopia
Infection and Drug Resistance
2021
Getie B.
Open Access
A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- To middle-income setting
Harm Reduction Journal
14 August 2020
Hariri S.
Open Access
The hepatitis C virus in Iran: Health policy, historical, ethical issues and future challenges
Journal of Preventive Medicine and Hygiene
2 April 2020
Behzadifar M.
Epidemiology of hepatitis c virus infection among 1,959 patients in shiraz, southern iran, between 1991 and 2016
Archives of Clinical Infectious Diseases
February 2020
Babaei A.H.
Open Access
The challenges of hepatitis C management in Iran: A qualitative study with patients
International Journal of Health Planning and Management
1 January 2020
Behzadifar M.
Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran
Infection Genetics and Evolution
November 2019
Cuypers L.
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran
International Journal of Drug Policy
November 2019
Moradi G.
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
International Journal of Drug Policy
October 2019
Alavi M.